38 results
8-K/A
ADVM
Adverum Biotechnologies Inc
4 Dec 23
Departure of Directors or Certain Officers
4:09pm
the applicable independence requirements of the Nasdaq Listing Rules. Upon the recommendation of the Nominating and Corporate Governance Committee
8-K
ADVM
Adverum Biotechnologies Inc
6 Nov 23
Departure of Directors or Certain Officers
4:10pm
. The Board has determined that Dr. Nicholson satisfies the applicable independence requirements of the Nasdaq Listing Rules. No committee assignment for Dr
PRE 14A
ypywjp
14 Apr 23
Preliminary proxy
6:03am
8-K
w4aigeqbvgastare
17 Mar 22
Departure of Directors or Certain Officers
4:36pm
DFAN14A
eqg64y9gsd94y9k
4 May 21
Additional proxy materials by non-management
10:11am
DFAN14A
EX-99.2
3hkvtqbc
22 Apr 21
Additional proxy materials by non-management
5:08pm
DFAN14A
EX-99.1
g9auwg05hdg4idno
19 Apr 21
Additional proxy materials by non-management
5:28pm
DEFC14A
nuan8q0ma9r69 xgv1r2
15 Apr 21
Proxy in contested solicitation
4:34pm
DEFC14A
yyeh 663j
15 Apr 21
Proxy in contested solicitation
6:03am
PRRN14A
wx9ukb3 r0timk640
13 Apr 21
Revised preliminary proxy statement filed by non-management
4:16pm
PREC14A
a55qtybd4fx
7 Apr 21
Preliminary proxy with contested solicitation
5:48pm
PRER14A
1nd 7gmmwn7esnvtbg
7 Apr 21
Preliminary revised proxy
4:28pm
PREC14A
yluiv
5 Apr 21
Preliminary proxy with contested solicitation
5:27pm